(firstQuint)ReNu Injection to Treat Hip Osteoarthritis Study.

 This is a prospective, non-randomized pilot study evaluating the efficacy of ReNu cent hip injection on patients with moderate osteoarthritis.

 The effects will be measured primarily through patient-reported outcomes questionnaires after a single injection.

 Patients will be followed up to 12 months to evaluate improvements using common pain and function subscales.

.

 ReNu Injection to Treat Hip Osteoarthritis Study@highlight

A pilot study to evaluate changes in hip function and pain in patients with osteoarthritis receiving the ReNu cent Hip Injection.

